SCHEMBL6682618

SCHEMBL6682618

Clc1ccc(Nc2ncnc3[nH]nc(-c4ccccc4)c23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.49
ABL1 P00519 6/20 0.49
CDK1 P06493 4/20 0.49
PRKCA P17252 4/20 0.49
MKNK1 Q9BUB5 1/20 0.49
TTBK1 Q5TCY1 1/20 0.47
TTBK2 Q6IQ55 1/20 0.47
SRC P12931 4/20 0.46
TRPA1 O75762 1/20 0.45
LRRK2 Q5S007 1/20 0.43
TP53 P04637 1/20 0.43
MAP4K4 O95819 2/20 0.43
PIM1 P11309 2/20 0.43
CLK4 Q9HAZ1 2/20 0.43
CDC7 O00311 2/20 0.43
DYRK3 O43781 1/20 0.43
CLK2 P49760 1/20 0.43
IRAK1 P51617 1/20 0.43
CSNK2A1 P68400 1/20 0.43
MAP4K2 Q12851 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6686751 0.95 EGFR (0.52) EGFRABL1CDK1PRKCAMKNK1
SCHEMBL19507722 0.91 EGFR (0.49) EGFRABL1CDK1PRKCATTBK1
SCHEMBL6235344 0.90 EGFR (0.55) EGFRABL1CDK1PRKCATTBK1
SCHEMBL6238000 0.84 ABCG2 (0.51) EGFRABL1PRKCATTBK1TTBK2
SCHEMBL6689654 0.84 FGFR1 (0.57) EGFRABL1CDK1PRKCATTBK1
SCHEMBL6684888 0.82 EGFR (0.52) EGFRABL1CDK1PRKCATTBK1
SCHEMBL19507769 0.82 EGFR (0.52) EGFRABL1CDK1PRKCASRC
SCHEMBL13861667 0.80 TTBK1 (0.52) EGFRABL1CDK1PRKCATTBK1
SCHEMBL6684639 0.79 LMNA (0.57) EGFRABL1CDK1PRKCATTBK1
SCHEMBL8116135 0.78 EGFR (0.69) EGFRABL1CDK1PRKCASRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832092-B1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS METABASIS THERAPEUTICS INC (US) 2004-11-17 EP disclosed
EP-0832092-A1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS GENSIA, INC. (US) 1998-04-01 EP disclosed
WO-1996040706-A1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS GENSIA-SICOR (US) 1996-12-19 WO disclosed